The use of a “gray zone” considering measurement uncertainty in pharmacological tests. The serum growth hormone stimulation test as an example-Reference-Cited by-同舟云学术

The use of a “gray zone” considering measurement uncertainty in pharmacological tests. The serum growth hormone stimulation test as an example

Published:2016-01-01 Issue:11 Volume:54 Page:
ISSN:1437-4331
Container-title:Clinical Chemistry and Laboratory Medicine (CCLM)
language:
Short-container-title:

Author:

Lazzati Juan Manuel,Zaidman Verónica,Maceiras Mercedes,Belgorosky Alicia,Chaler Eduardo

Publisher

Walter de Gruyter GmbH

Subject

Biochemistry, medical,Clinical Biochemistry,General Medicine

Link

https://www.degruyter.com/document/doi/10.1515/cclm-2015-0954/pdf

Reference16 articles.

1. Cut-off values of serum growth hormone (GH) in pharmacological stimulation tests (PhTs) evaluated in short-statured children using a chemiluminescent immunometric assay (ICMA) calibrated with the International Recombinant Human GH Standard 98/574;Clin Chem Lab Med,2013

2. Between-assay differences in serum growth hormone (GH) measurements: importance in the diagnosis of GH deficiency in childhood;Clin Chem,2001

3. Harmonization in laboratory medicine: the complete picture;Clin Chem Lab Med,2013

4. Interpretation of growth hormone provocative tests: comparison of cut-off values in four European laboratories;Eur J Endocrinol,1995

5. The continuum of growth hormone-IGF-I-axis defects causing short stature: diagnostic and therapeutic challenges;Clin Endocrinol,2010

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Robustness of CSF Aβ42/40 and Aβ42/P‐tau181 measured using fully automated immunoassays to detect AD‐related outcomes;Alzheimer's & Dementia;2023-01-21

2. Reducing the need for repeating urine drug testing with the gray zone determined by the measurement uncertainty;Journal of Medical Biochemistry;2023

3. Total Analytical Error and Measurement Uncertainty for Analytical Performance Evaluation and Determination of Gray Zones of Glucose Critical Value Limits;Laboratory Medicine;2022-09-02

4. Test‐retest variability of plasma biomarkers in Alzheimer's disease and its effects on clinical prediction models;Alzheimer's & Dementia;2022-06-14